Immunology of bovine respiratory syncytial virus infection of cattle

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 35, Issue 3, 2012, Pages 253-257

  Gershwin, Laurel J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bovine respiratory syncytial virus; IgE; Immunity; Immunomodulation; Vaccine

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; VIRUS VACCINE;

ARTICLE; BOVINE RESPIRATORY SYNCYTIAL VIRUS INFECTION; CATTLE DISEASE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; EXPERIMENTAL INFECTION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFECTION CONTROL; INFECTION PREVENTION; INNATE IMMUNITY; INTERFERON PRODUCTION; NONHUMAN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VACCINATION; VIRUS INACTIVATION;

ANIMALS; CATTLE; CATTLE DISEASES; DENDRITIC CELLS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN E; INTERFERON-GAMMA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; TH1 CELLS; VACCINATION;

BOS; BOVINAE; BOVINE RESPIRATORY SYNCYTIAL VIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84859724991     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2012.01.005     Document Type: Article

References (30)

1. Larsen L.E. Bovine respiratory syncytial virus (BRSV): a review. Acta Vet Scand 2000, 41(1):1-24.
2. Taylor G., Thomas L.H., Furze J.M., Cook R.S., Wyld S.G., Lerch R., et al. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions. J Gen Virol 1997, 78(December (Pt 12)):3195-3206.
3. Valarcher J.F., Schelcher F., Bourhy H. Evolution of bovine respiratory syncytial virus. J Virol 2000, 74(November (22)):10714-10728.
4. Bueno S.M., González P.A., Pacheco R., Leiva E.D., Cautivo K.M., Tobar H.E., et al. Host immunity during RSV pathogenesis. Int Immunopharmacol 2008, 8(October (10)):1320-1329.
5. Shadman K.A., Wald E.R. A review of palivizumab and emerging therapies for respiratory syncytial virus. Expert Opin Biol Ther 2011, 11(November (11)):1455-1467.
6. Welliver R.C., Duffy L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol 1993, 15(January (1)):19-27.
7. Gershwin L.J., Anderson M.L., Wang C., Berghaus L.J., Kenny T.P., Gunther R.A. Assessment of IgE response and cytokine gene expression in pulmonary efferent lymph collected after ovalbumin inhalation during experimental infection of calves with bovine respiratory syncytial virus. Am J Vet Res 2011, 72(January (1)):134-145.
8. Werling D., Koss M., Howard C.J., Taylor G., Langhans W., Hope J.C. Role of bovine chemokines produced by dendritic cells in respiratory syncytial virus-induced T cell proliferation. Vet Immunol Immunopathol 2002, 87(September (3-4)):225-233.
9. Lizundia R., Sauter K.S., Taylor G., Werling D. Host species-specific usage of the TLR4-LPS receptor complex. Innate Immun 2008, 14(August (4)):223-231.
10. Das S., Palmer O.P., Leight W.D., Surowitz J.B., Pickles R.J., Randell S.H., et al. Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells. Laryngoscope 2005, 115(May (5)):764-768.
11. Tizard I.R. Veterinary immunology, an introduction 2009, Saunders. Elsevier, St. Louis, MO, [chapter 2]. 8th ed.
12. Kimman T.G., Westenbrink F., Schreuder B.E., Straver P.J. Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies. J Clin Microbiol 1987, 25(June (6)):1097-1106.
13. Knott I., Weynants V., Walravens K., van der Poel W.H., Kramps J.A., Letesson J.J. Immune response of calves experimentally infected with non-cell-culture-passaged bovine respiratory syncytial virus. Arch Virol 1998, 143(6):1119-1128.
14. Collie D.D. Pulmonary function changes and clinical findings associated with chronic respiratory disease in calves. Br Vet J 1992, 148:33-40.
15. Woolums A.R., Anderson M.L., Gunther R.A., Schelegle E.S., LaRochelle D.R., Singer R.S., et al. Evaluation of severe disease induced by aerosol inoculation of calves with bovine respiratory syncytial virus. Am J Vet Res 1999, 60(April (4)):473-480.
16. Gershwin L.J., Gunther R.A., Anderson M.L., Woolums A.R., McArthur-Vaughan K., Randel K.E., et al. Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and-4, and interferon-γ expression in pulmonary lymph of experimentally infected calves. Am J Vet Res 2000, 61(March (3)):291-298.
17. Stewart R.S., Gershwin L.J. Detection of IgE antibodies to bovine respiratory syncytial virus. Vet Immunol Immunopathol 1989, 20(March (4)):313-323.
18. Stewart R.S., Gershwin L.J. Role of IgE in the pathogenesis of bovine respiratory syncytial virus in sequential infections in vaccinated and non-vaccinated calves. Am J Vet Res 1989, 50(March (3)):349-355.
19. Woolums A.R., Gunther R.A., McArthur-Vaughan K., Anderson M.L., Omlor A., Boyle G.A., et al. Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge. Comp Immunol Microbiol Infect Dis 2004, 27(January (1)):57-74.
20. Gaddum R.M., Cook R.S., Thomas L.H., Taylor G. Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves. Immunology 1996, 88(July (3)):421-427.
21. Gershwin L.J., Schelegle E.S., Gunther R.A., Anderson M.L., Woolums A.R., Larochelle D.R., et al. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 1998, 16(July (11-12)):1225-1236.
22. Woolens A.R., Singer R.S., Boyle G.A., Gershwin L.J. Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin inactivated BRSV. Vaccine 1999, 17(March (11-12)):1293-1297.
23. Kimman T.G., Sol J., Westenbrink F., Straver P.J. A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine. Vet Q 1989, 11(October (4)):250-253.
24. Schreiber P., Matheise J.P., Dessy F., Heimann M., Letesson J.J., Coppe P., et al. High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine. J Vet Med B: Infect Dis Vet Public Health 2000, 47:535-550.
25. Antonis A.F., Claassen E.A., Hensen E.J., de Groot R.J., de Groot-Mijnes J.D., Schrijver R.S., et al. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection. Vaccine 2006, 24(March (10)):1551-1561.
26. Ellis J., Gow S., West K., Waldner C., Rhodes C., Mutwiri G., et al. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration. J Am Vet Med Assoc 2007, 230(January (2)):233-243.
27. Oumouna M., Mapletoft J.W., Karvonen B.C., Babiuk L.A., van Drunen Littel-van denHurk S. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine. J Virol 2005, 79(February (4)):2024-2032.
28. Lin K.-F., McArthur-Vaughan K., Rhodes G.H., Gershwin L.J. Evaluation of CDNA vaccines coding for F or N proteins of bovine respiratory syncytial virus: clinical outcome and immune response. American Society for Virology, 22nd Annual Meeting 2003.
29. Letellier C., Boxus M., Rosar L., Toussaint J.F., Walravens K., Roels S., et al. Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology. Vaccine 2008, 26(September (37)):4840-4848.
30. Riffault S., Meyer G., Deplanche M., Dubuquoy C., Durand G., Soulestin M., et al. A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus. Vaccine 2010, 28(May (21)):3722-3734.